A viral 'loose cannon' enzyme helps phages shut down bacterial defenses

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

As antimicrobial resistance grows around the world, novel therapies to counter it become increasingly important. Phages—viruses that infect bacteria—are an exciting avenue of research in this regard, providing a means to selectively kill pathogenic bacteria, even those resistant to traditional antibiotics.